Fig. 5.
Treatment with forskolin or PGE1 increases phosphorylation of GPIbβ in GPIb/V/IX-transfected cells and platelets, an effect reversed by RAM.1.

Treatment with forskolin or PGE1 increases phosphorylation of GPIbβ in GPIb/V/IX-transfected cells and platelets, an effect reversed by RAM.1.

K562-GPIb/V/IX, K562-GPIb(βSer166Gly)/V/IX cells, or human platelets were labeled with [32P]PO4, then preincubated with 10 μg/mL RAM.1 (+) or rat control IgG (-) and treated with dimethyl sulfoxide (resting), 10 μM PGE1 (+PGE1), or 10 μM forskolin (+Fsk) for 10 minutes at 37°C. Following cell lysis, the GPIb/V/IX complex was immunoprecipitated by RAM.1 and proteins were separated on a 7.5%-15% SDS-PAGE gel. Gels were analyzed by autoradiography or using the phosphoimager system. Results are representative of 2 separate experiments. Forskolin or PGE1 treatment increased the GPIbβ phosphorylation on both platelets and K562-GPIb/V/IX cells whereas RAM.1 switched it off. In contrast, forskolin and PGE1 had no effect on phosphorylation of the GPIbβ(Ser166Gly) subunit.

Close Modal

or Create an Account

Close Modal
Close Modal